Biocon Ltd.

NSE: BIOCON | BSE: 532523 | ISIN: INE376G01013 | Industry: Biotechnology
| Mid-range Performer
365.2000 1.15 (0.32%)
NSE Sep 12, 2025 15:31 PM
Volume: 1.2M
 

logo
Biocon Ltd.
31 Jul 2017
365.20
0.32%
ICICI Securities Limited
ICICI Securities Ltd | Retail Equity Research Revenues declined 6% YoY to | 934 crore (I-direct estimate: | 955 crore) due to sluggish API sales, adverse currency movement, GST impact, fire incident at Syngene and lower licensing income EBITDA margins contracted 595 bps YoY to 20.6% (I-direct estimate: 21.2%) mainly due to commissioning of the Malaysian plant Net profit fell 51% YoY to | 81 crore (I-direct estimate: | 88 crore) due to below expected operational performance, higher depreciation...
Institutional Investors have increased holdings from 21.40% to 28.87% in Jun 2025 qtr.
More from Biocon Ltd.
Recommended